Trials / Sponsors / Guangzhou Henovcom Bioscience Co. Ltd.
Guangzhou Henovcom Bioscience Co. Ltd.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Relative Bioavailability Study of HNC364 Injectable Suspension Parkinson's Disease (PD) | Phase 1 | 2025-05-01 |
| Completed | A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058 IPF | Phase 1 | 2023-03-28 |
| Completed | A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension Parkinson's Disease | Phase 1 | 2022-08-22 |
| Completed | A Study of HNC664 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics Healthy | Phase 1 | 2020-08-11 |
| Completed | A Study of HNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics Influenza | Phase 1 | 2020-08-01 |
| Completed | A Study of HNC042 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics. Healthy | Phase 1 | 2018-11-09 |